Bnp Paribas »

Vertex Pharmaceuticals Incorporated shares owned by Bnp Paribas

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Bnp Paribas from 13F filings

Historical chart of Bnp Paribas investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Bnp Paribas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Bnp Paribas

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.0M 7.1k 418.01

More positions owned by Bnp Paribas

Microsoft Corp Equities (MSFT)
iShares iBoxx $ Investment Grade Corporate Bond ETF Fund (LQD)
Invesco Senior Loan ETF Fund (BKLN)
Apple Equities (AAPL)
Nvidia Corporation Equities (NVDA)
Amazon Equities (AMZN)
Salesforce Equities (CRM)
Alphabet Inc Cap Stk Cl C Equities (GOOG)
Visa Inc Com Cl A Equities (V)
Jpmorgan Chase & Co Equities (JPM)
Applied Matls Equities (AMAT)
Merck & Co Equities (MRK)
Disney Walt Equities (DIS)
Palo Alto Networks Equities (PANW)
Broadcom Equities (AVGO)

View all positions for Bnp Paribas

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated